Honey bee venom

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The practice of using honey bee or its products (raw honey, royal jelly, pollen, propolis, bee venom and bees wax) for medical… (More)
  • table 1
Is this relevant?
2016
2016
BACKGROUND Component resolution recently identified distinct sensitization profiles in honey bee venom (HBV) allergy, some of… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Background Honey bee (HB) venom immunotherapy (HBVIT) reduces the frequency of immediate generalised reactions (IGR) to… (More)
Is this relevant?
2011
2011
The honey bee colonies, with the relevant number of immature brood and adults, and stable, high levels of humidity and… (More)
Is this relevant?
2002
2002
Bee venom has been reported to exhibit antitumour activity in-vitro and in-vivo. Apoptosis, necrosis and lysis of tumour cells… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The present study describes a new test of tonic pain to be used as an animal model of persistent pain. First, pain responses and… (More)
Is this relevant?
1994
1994
Clinical study was conducted on 77 adult patients with hypersensitivity to honey bee venom (HBV) to determine clinical… (More)
Is this relevant?
1992
1992
In a double-blind placebo-controlled trial on 52 patients with bee venom allergy we studied the effect of a pretreatment with… (More)
Is this relevant?
1988
1988
Immunotherapy with hymenoptera venoms is safe and effective in most patients but treatment failures have been reported. Five… (More)
Is this relevant?
1987
1987
Phospholipase A2 (E.C. 3.1.1.4.) is a major allergen of honey bee venom. It exists in a glycosylated and an unglycosylated… (More)
Is this relevant?